自发冠状动脉剖析和戒毒
Alfredo Mauriello1,2, Adriana Correra2
1Department of Medical and Translational Sciences, Cardiology Unit, University of Campania Luigi Vanvitelli, Monaldi Hospital, Naples, Italy.
Journal of cardiovascular echography
|September 15, 2025
概括
自发冠状动脉解剖 (SCAD) 是心脏病发作的罕见原因. 这一案例突显了SCAD导致中年男性在药物戒断期间心肌梗塞.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 自发冠状动脉解剖 (SCAD) 是急性冠状动脉综合征的一个不常见的原因.
- SCAD可以自发发生,也可以是阳性,与各种潜在疾病有关.
研究的目的:
- 报告一个罕见的ST升高心肌梗塞病例,由左主冠状动脉剖析引起.
- 探索SCAD和戒毒危机之间的关联.
主要方法:
- 案例报告的呈现方式.
- 对临床表现,诊断结果和管理的审查.
主要成果:
- 一名47岁的男性出现了ST升高心肌梗塞.
- 这次心脏病发作归因于左主冠状动脉解剖.
- 这一事件发生在戒毒危机的背景下.
结论:
- 药物戒断可能是SCAD未被认可的沉剂.
- 左主冠状动脉解剖是SCAD的一个关键表现,需要迅速识别和管理.
相关概念视频
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
363
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
363
Coronary Artery Disease III: Clinical Manifestations
330
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
330
Acute Coronary Syndrome I: Introduction
828
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
828
Acute Coronary Syndrome III: Diagnostic Studies
218
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
218
Coronary Artery Disease II: Pathophysiology
375
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
375
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K


